1. Home
  2. LUNG vs EVG Comparison

LUNG vs EVG Comparison

Compare LUNG & EVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • EVG
  • Stock Information
  • Founded
  • LUNG 1995
  • EVG 2005
  • Country
  • LUNG United States
  • EVG United States
  • Employees
  • LUNG N/A
  • EVG N/A
  • Industry
  • LUNG Industrial Specialties
  • EVG Investment Managers
  • Sector
  • LUNG Health Care
  • EVG Finance
  • Exchange
  • LUNG Nasdaq
  • EVG Nasdaq
  • Market Cap
  • LUNG 124.0M
  • EVG 146.4M
  • IPO Year
  • LUNG 2020
  • EVG N/A
  • Fundamental
  • Price
  • LUNG $2.67
  • EVG $10.80
  • Analyst Decision
  • LUNG Buy
  • EVG
  • Analyst Count
  • LUNG 6
  • EVG 0
  • Target Price
  • LUNG $11.53
  • EVG N/A
  • AVG Volume (30 Days)
  • LUNG 366.5K
  • EVG 49.4K
  • Earning Date
  • LUNG 07-30-2025
  • EVG 01-01-0001
  • Dividend Yield
  • LUNG N/A
  • EVG 8.68%
  • EPS Growth
  • LUNG N/A
  • EVG N/A
  • EPS
  • LUNG N/A
  • EVG N/A
  • Revenue
  • LUNG $87,473,000.00
  • EVG N/A
  • Revenue This Year
  • LUNG $18.02
  • EVG N/A
  • Revenue Next Year
  • LUNG $18.17
  • EVG N/A
  • P/E Ratio
  • LUNG N/A
  • EVG N/A
  • Revenue Growth
  • LUNG 19.84
  • EVG N/A
  • 52 Week Low
  • LUNG $2.62
  • EVG $9.13
  • 52 Week High
  • LUNG $9.37
  • EVG $10.86
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 33.53
  • EVG 47.01
  • Support Level
  • LUNG $2.62
  • EVG $10.80
  • Resistance Level
  • LUNG $3.52
  • EVG $11.11
  • Average True Range (ATR)
  • LUNG 0.23
  • EVG 0.10
  • MACD
  • LUNG 0.02
  • EVG -0.00
  • Stochastic Oscillator
  • LUNG 13.46
  • EVG 22.50

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.

Share on Social Networks: